Osteoblast-intrinsic defect in glucose metabolism impairs bone formation in type II diabetic male mice
eLife · 05.05.2023 · 12
DOI: 10.7554/elife.85714 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 05.05.2023. Verfasst von Fangfang Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Program in Pediatric Orthopedics, Department of Surgery, The Children's Hospital of Philadelphia, Philadelphia, United States. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Skeletal fragility is associated with type 2 diabetes mellitus (T2D), but the underlying mechanism is not well understood. Here, in a mouse model for youth-onset T2D, we show that both trabecular and cortical bone mass is reduced due to diminished osteoblast activity. Stable isotope tracing in vivo with 13 C-glucose demonstrates that both glycolysis and glucose fueling of the TCA cycle are impaired in diabetic bones. Similarly, Seahorse assays show suppression of both glycolysis and oxidative phosphorylation by diabetes in bone marrow mesenchymal cells as a whole, whereas single-cell RNA sequencing reveals distinct modes of metabolic dysregulation among the subpopulations. Metformin not only promotes glycolysis and osteoblast differentiation in vitro, but also improves bone mass in diabetic mice. Finally, osteoblast-specific overexpression of either Hif1a, a general inducer of glycolysis, or Pfkfb3 which stimulates a specific step in glycolysis, averts bone loss in T2D mice. The study identifies osteoblast-intrinsic defects in glucose metabolism as an underlying cause of diabetic osteopenia, which may be targeted therapeutically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Research Program in Pediatric Orthopedics, Department of Surgery, The Children's Hospital of Philadelphia, Philadelphia, United States.
- The State Key Laboratory Breeding Base of Basic Science of Stomatology and Key Laboratory for Oral Biomedicine of Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China.
- Lewis Sigler Institute for Integrative Genomics, Princeton University, Princeton, United States.
- Department of Computer Science, New Jersey Institute of Technology, Newark, United States.
- Deaprtment of Orthopedic Surgery, University of Pennsylvania, Philadelphia, United States.
ORCID-Profile: Fangfang Song, Won Dong Lee, Fanxin Long
Förderung
- NIAMS NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Song, F., Lee, W. D., Marmo, T., Ji, X., Song, C., Liao, X., Seeley, R., Yao, L., Liu, H., & Long, F. (2023). Osteoblast-intrinsic defect in glucose metabolism impairs bone formation in type II diabetic male mice. eLife, 12. https://doi.org/10.7554/elife.85714
Vancouver
Song F, Lee WD, Marmo T, Ji X, Song C, Liao X, et al. Osteoblast-intrinsic defect in glucose metabolism impairs bone formation in type II diabetic male mice. eLife. 2023;12. doi:10.7554/elife.85714
BibTeX
@article{Song2023,
author = {Song, Fangfang and Lee, Won Dong and Marmo, Tyler and Ji, Xing and Song, Chao and Liao, Xueyang and Seeley, Rebecca and Yao, Lutian and Liu, Haoran and Long, Fanxin},
title = {Osteoblast-intrinsic defect in glucose metabolism impairs bone formation in type II diabetic male mice},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.85714}
}
EUVIMED